Literature DB >> 1613800

Co-optimization of ribozyme substrate stacking and L-arginine binding.

M Yarus1, I Majerfeld.   

Abstract

A model of the Tetrahymena catalytic site predicts that nucleotide 262 (nt262) caps an RNA pocket in which nucleoside substrates and arginine-like competitive inhibitors reside. Here we show that substituted RNAs behave as if nt262 stacks on nucleoside substrates, supporting the model. The more frequent an nt262 is in natural sequences, the more reactive the corresponding Tetrahymena RNA is for both cognate and non-cognate nucleoside substrates. These more reactive RNAs with the majority nt262 also bind arginine more strongly, stereoselect more strongly in favor of L-arginine, and make a greater distinction between the somewhat similar side-chains of L-arginine and L-lysine. These parallel changes in interaction with nucleosides and arginine analogs seem best explained by stacking of the arginine's guanidino group under the nt262 base. One consequence is that selection for improved Tetrahymena catalysis with nucleosides should also yield an improved arginine site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613800     DOI: 10.1016/0022-2836(92)90095-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Solution structure of an RNA fragment with the P7/P9.0 region and the 3'-terminal guanosine of the tetrahymena group I intron.

Authors:  Aya Kitamura; Yutaka Muto; Satoru Watanabe; Insil Kim; Takuhiro Ito; Yoichi Nishiya; Kensaku Sakamoto; Takashi Ohtsuki; Gota Kawai; Kimitsuna Watanabe; Kazumi Hosono; Hiroshi Takaku; Etsuko Katoh; Toshimasa Yamazaki; Tan Inoue; Shigeyuki Yokoyama
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

Review 2.  RNA-amino acid binding: a stereochemical era for the genetic code.

Authors:  Michael Yarus; Jeremy Joseph Widmann; Rob Knight
Journal:  J Mol Evol       Date:  2009-10-01       Impact factor: 2.395

3.  Role of RNA structure in arginine recognition of TAR RNA.

Authors:  J D Puglisi; L Chen; A D Frankel; J R Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

4.  An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine recognition.

Authors:  D Kiga; Y Futamura; K Sakamoto; S Yokoyama
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

5.  Inhibition of self-splicing group I intron RNA: high-throughput screening assays.

Authors:  H Y Mei; M Cui; S T Sutton; H N Truong; F Z Chung; A W Czarnik
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

6.  Bidirectional effectors of a group I intron ribozyme.

Authors:  Y Liu; M J Leibowitz
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

7.  Mutations at the guanosine-binding site of the Tetrahymena ribozyme also affect site-specific hydrolysis.

Authors:  P Legault; D Herschlag; D W Celander; T R Cech
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

8.  An RNA fragment consisting of the P7 and P9.0 stems and the 3'-terminal guanosine of the Tetrahymena group I intron.

Authors:  S Watanabe; G Kawai; Y Muto; K Watanabe; T Inoue; S Yokoyama
Journal:  Nucleic Acids Res       Date:  1996-04-01       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.